Mitochondrial Disease
Resources
Medications
Insurance Assistance
Forzinity
Kygevvi
Skyclarys
Get Involved
Research
About Us
About Us
2026-2029 Strategic Plan
2025 Annual Report
Donate
Donate Now
Energy for Life
Family Tribute Pages
Match Your Gift
Get Support
Saol Therapeutics Provides Update from Type C Meeting with FDA regarding DCA
Mito Advocacy
,
Press Room
Last Updated:
Apr 1, 2026 @ 10:05 am
Search for:
Categories
About Mito
Conference
Research News
Position Statements
Corporate Partner
Fundraising
Mito Champion Spotlight
Donor Spotlight
Recent Posts
July 2026 Newsletter: Mito Med 2026 Recap
Saol Therapeutics Announces Resubmission of DCA for the Treatment of PDCD
UMDF and Mito Foundation Announce 2026 Research Grant Program Award Winners
June 2026 Newsletter: Time for Mito Med 2026
Ask the Mito Doc – March 2026
April 2026 Newsletter: 30 Years of Progress
Related Posts
July 2026 Newsletter: Mito Med 2026 Recap
Read article: July 2026 Newsletter: Mito Med 2026 Recap
Saol Therapeutics Announces Resubmission of DCA for th...
Read article: Saol Therapeutics Announces Resubmission of DCA for the Treatment of PDCD
UMDF and Mito Foundation Announce 2026 Research Grant ...
Read article: UMDF and Mito Foundation Announce 2026 Research Grant Program Award Winners
